Abstract:Colorectal cancer (CRC), a malignancy affecting the colon and rectum, ranks as the third most common cancer worldwide and the second leading cause of cancer-related deaths. Early detection of CRC is crucial for preventing metastasis, reducing mortality, improving prognosis, and enhancing patients' quality of life. Genetic factors play a significant role in CRC development, accounting for up to 35% of the disease risk. Genome-wide association studies have identified several genetic loci associated with CRC risk. However, these studies often lack direct evidence of causality. While traditional blood biomarkers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are widely used for CRC diagnosis and monitoring, their sensitivity and accuracy in early diagnosis are limited. Thus, there is a pressing need to develop new biomarkers that reflect the genetic background of CRC to improve early detection and diagnostic accuracy. In addition, understanding the genetic mechanisms underlying these biomarkers is essential for elucidating CRC pathogenesis and developing precise personalized treatment strategies. Mendelian randomization (MR) analysis, as an emerging epidemiological tool, can accurately assess the causal relationship between genetic variations and diseases by reducing confounding biases in observational studies. MR analysis has been applied in evaluating the causal impact of various blood biomarkers on CRC risk, shedding lights on the potential causal relationships between these biomarkers and CRC pathogenesis in the context of genetic background. In this review, we summarize the applications of MR analysis in studies of blood biomarkers for CRC, aiming to enhance the early diagnosis and personalized treatment of CRC.

[Research progress of Mendelian randomization analysis in intensive care medicine]

Mendelian Randomization Studies: Opening a New Window in the Study of Metabolic Diseases and Chronic Kidney Disease

Using Mendelian Randomization As the Cornerstone for Causal Inference in Epidemiology.

The Application of Mendelian Randomization in Cardiovascular Disease Risk Prediction: Current Status and Future Prospects

Mendelian Randomization Analysis in Observational Epidemiology

Mendelian randomization: causal inference leveraging genetic data

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

Use of Mendelian randomization to assess the causal status of modifiable exposures for rheumatic diseases

Benchmarking Mendelian Randomization methods for causal inference using genome-wide association study summary statistics

Mendelian Randomization: Concepts and Scope

Application of mendelian randomization in ocular diseases: a review

Advances in the application of Mendelian randomization in investigating the etiologies of common diseases in the elderly

Application of Mendelian randomization analysis in investigating the genetic background of blood biomarkers for colorectal cancer

A Guide to Understanding Mendelian Randomization Studies

Mendelian randomization analyses in ocular disease: a powerful approach to causal inference with human genetic data

Mendelian randomization in cardiometabolic disease: challenges in evaluating causality

Mendelian Randomization With Refined Instrumental Variables From Genetic Score Improves Accuracy and Reduces Bias

Recent advances in the application of Mendelian randomization to chronic kidney disease

Causal inference in health and disease: a review of the principles and applications of Mendelian randomization

Causal inference in the field of arrhythmia: An introduction to mendelian randomization

Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases